CVS Health Corporation (CVS)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
As of 12:40PM EDT. Market open.
| Previous close | 67.77 |
| Open | 67.50 |
| Bid | 67.20 x 1100 |
| Ask | 67.23 x 800 |
| Day's range | 66.88 - 67.75 |
| 52-week range | 64.41 - 83.25 |
| Volume | |
| Avg. volume | 9,455,201 |
| Market cap | 84.828B |
| Beta (5Y monthly) | 0.51 |
| PE ratio (TTM) | 10.40 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 2.66 (3.93%) |
| Ex-dividend date | 19 Apr 2024 |
| 1y target est | N/A |
- Yahoo Finance
Walgreens launches specialty pharmacy unit to compete in new PBM era
Walgreens is launching new services and consolidating specialty services to compete in the pharmacy benefits management (PBM) space.
- Zacks
Earnings Preview: CVS Health (CVS) Q1 Earnings Expected to Decline
CVS Health (CVS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
Wall Street Analysts Think CVS Health (CVS) Is a Good Investment: Is It?
The average brokerage recommendation (ABR) for CVS Health (CVS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
© 2024 Yahoo. All rights reserved.